Freestone Capital Holdings »

Immunome shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $722k 62k 11.71
2025-06-30 $573k 62k 9.30
2025-03-31 $415k 62k 6.73

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Put Option (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)

View all positions for Freestone Capital Holdings

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Redmile Group
Vanguard Group
Point72 Asset Management
Enavate Sciences GP
Leucadia National Corporation
EcoR1 Capital
Opaleye Management
PRIMECAP Management Company
State Street Corporation
Caption Management
Toronto-Dominion Bank
Geode Capital Management

View all funds holding Immunome